Cargando…

Seronegative Erosive Arthritis Following SARS-CoV-2 Infection

Coronavirus disease 2019 (COVID-19) is caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) affecting mostly the respiratory system, but several other organs and systems can be involved. Extrapulmonary manifestations and autoimmune phenomena following SARS-CoV-2 infection are f...

Descripción completa

Detalles Bibliográficos
Autores principales:	Drosos, Alexandros A., Pelechas, Eleftherios, Voulgari, Paraskevi V.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer Healthcare 2021
Materias:	Case Report
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8594638/ https://www.ncbi.nlm.nih.gov/pubmed/34786669 http://dx.doi.org/10.1007/s40744-021-00395-9

Ejemplares similares

Colchicine Against SARS-CoV-2 Infection: What is the Evidence?
por: Drosos, Alexandros A., et al.
Publicado: (2022)

A Response to: Letter to the Editor Regarding the Article: “Colchicine Against SARS-CoV-2 Infection: What is the Evidence?”
por: Drosos, Alexandros A., et al.
Publicado: (2022)

Golimumab for Rheumatoid Arthritis
por: Pelechas, Eleftherios, et al.
Publicado: (2019)

Clinical evaluation of the safety, efficacy and tolerability of sarilumab in the treatment of moderate to severe rheumatoid arthritis
por: Pelechas, Eleftherios, et al.
Publicado: (2019)

Rheumatoid Arthritis Treatment. A Back to the Drawing Board Project or High Expectations for Low Unmet Needs?
por: Drosos, Alexandros A., et al.
Publicado: (2019)

Anti-Rheumatic Drugs for the Fight Against the Novel Coronavirus Infection (SARSCoV-2): What is the Evidence?
por: Pelechas, Eleftherios, et al.
Publicado: (2020)

Anti-Rheumatic Drugs May Ameliorate the Clinical Course and Outcome of COVID-19 In Rheumatoid Arthritis Patients
por: Pelechas, Eleftherios, et al.
Publicado: (2022)

A Case of Recalcitrant Psoriatic Arthritis to TNF Inhibitors Improved After Administration of Secukinumab, an IL-17A Inhibitor
por: Pelechas, Eleftherios, et al.
Publicado: (2017)

A not-to-miss Cause of Severe Cervical Spine Pain in a Patient with Rheumatoid Arthritis: A Case-Based Review
por: Drosos, Alexandros A., et al.
Publicado: (2021)

Long COVID from rheumatology perspective: a simple mimicker or promoter of autoimmunity?
por: Drosos, Alexandros A., et al.
Publicado: (2022)

A Patient with Symmetrical Polyarthritis. The Value of Conventional Radiography for a Correct Diagnosis
por: Drosos, Alexandros A., et al.
Publicado: (2022)

Treatment strategies of COVID-19: A rheumatology perspective
por: Drosos, Alexandros A., et al.
Publicado: (2022)

Maintained Clinical Remission in Ankylosing Spondylitis Patients Switched from Reference Infliximab to Its Biosimilar: An 18-Month Comparative Open-Label Study
por: Kaltsonoudis, Evripidis, et al.
Publicado: (2019)

An uncommon presentation of Granulomatosis with Polyangiitis
por: Pelechas, Eleftherios, et al.
Publicado: (2018)

COVID-19 in patients with gout on colchicine
por: Pelechas, Eleftherios, et al.
Publicado: (2021)

Comment on the Article “Adalimumab-Induced Lupus Nephritis: Case Report and Review of the Literature”
por: Drosos, Alexandros A., et al.
Publicado: (2023)

Biologic Therapies and Autoimmune Phenomena
por: Drosos, Alexandros A., et al.
Publicado: (2021)

The impact of temporal artery biopsy for the diagnosis of giant cell arteritis in clinical practice in a tertiary university hospital
por: Kaltsonoudis, Evripidis, et al.
Publicado: (2019)

Use of conventional synthetic and biologic disease-modifying anti-rheumatic drugs in patients with rheumatic diseases contracting COVID-19: a single-center experience
por: Migkos, Michalis P., et al.
Publicado: (2021)

Fasting mimicking diets: A literature review of their impact on inflammatory arthritis
por: Venetsanopoulou, Aliki I., et al.
Publicado: (2019)

Dermatomyositis sine myositis – Case presentation
por: Kaltsonoudis, Evripidis, et al.
Publicado: (2017)

The usefulness of magnetic resonance imaging of the hand and wrist in very early rheumatoid arthritis
por: Kosta, Paraskevi E, et al.
Publicado: (2011)

Long-term use of adalimumab in the treatment of rheumatic diseases
por: Papagoras, Charalampos, et al.
Publicado: (2009)

Seronegative Myasthenia Gravis with Concomitant SARS-CoV-2 Infection in a Dog
por: Musteata, Mihai, et al.
Publicado: (2022)

Evidence of previous SARS-CoV-2 infection in seronegative patients with long COVID
por: Krishna, Benjamin A., et al.
Publicado: (2022)

Memory T cell responses in seronegative older adults following SARS-CoV-2 vaccination
por: Hafızoğlu, Merve, et al.
Publicado: (2022)

Cellular immunity to SARS-CoV-2 following intrafamilial exposure in seronegative family members
por: Jay, Cecilia, et al.
Publicado: (2023)

Seronegative immunity to SARS-CoV-2: a case study
por: Miller, Kyle D., et al.
Publicado: (2022)

Cellular Immune Responses to SARS-CoV-2 in Exposed Seronegative Individuals
por: Norton, Natasha J., et al.
Publicado: (2023)

Clinical, Serological and Immunological Characteristics in Greek Patients with Psoriatic Arthritis: The Role of IL-17, IL-23, and Sclerostin
por: Venetsanopoulou, Aliki I., et al.
Publicado: (2020)

Exposed seronegative: Cellular immune responses to SARS-CoV-2 in the absence of seroconversion
por: Jay, Cecilia, et al.
Publicado: (2023)

Risk Factors for Being Seronegative following SARS-CoV-2 Infection in a Large Cohort of Health Care Workers in Denmark
por: Johannesen, Caroline Klint, et al.
Publicado: (2021)

Persistent T-Cell Reactivity in a Seronegative Patient after SARS-CoV-2 Infection and One Vaccination
por: Andreas, Nico, et al.
Publicado: (2022)

Pre-existing polymerase-specific T cells expand in abortive seronegative SARS-CoV-2
por: Swadling, Leo, et al.
Publicado: (2021)

SARS-CoV-2-Seronegative Subjects Target CTL Epitopes in the SARS-CoV-2 Nucleoprotein Cross-Reactive to Common Cold Coronaviruses
por: Schmidt, Katja G., et al.
Publicado: (2021)

Arthritis after SARS-CoV-2 infection
por: Baimukhamedov, Chokan, et al.
Publicado: (2021)

Eight-year survival study of first-line tumour necrosis factor α inhibitors in rheumatoid arthritis: real-world data from a university centre registry
por: Papadopoulos, Christos G, et al.
Publicado: (2019)

Acute arthritis following SARS‐CoV‐2 infection: About two cases
por: Brahem, Mouna, et al.
Publicado: (2023)

A fourth SARS-CoV-2 mRNA vaccine in strictly seronegative kidney transplant recipients
por: Masset, Christophe, et al.
Publicado: (2022)

Reactive arthritis after SARS-CoV-2 infection
por: Sureja, Nayan Patel, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_fhalraboljksb9coeb94s5n29o